• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

东欧血统重症肌无力患者的自身免疫性和非自身免疫性合并症:一项病例对照研究。

Autoimmune and Non-Autoimmune Comorbidities in Myasthenic Patients of East-European Descent: A Case-Control Study.

作者信息

Croitoru Cristina Georgiana, Pavel-Tanasa Mariana, Cuciureanu Dan Iulian, Hodorog Diana Nicoleta, Cianga Petru

机构信息

I Neurology Clinic, "Prof. Dr. Nicolae Oblu" Emergency Clinical Hospital, 700309 Iași, Romania.

Department of Immunology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iași, Romania.

出版信息

J Clin Med. 2024 Apr 14;13(8):2273. doi: 10.3390/jcm13082273.

DOI:10.3390/jcm13082273
PMID:38673546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11051044/
Abstract

As the life expectancy of patients with myasthenia gravis (MG) is improving, so the number of comorbidities continues to rise, with a potentially significant impact on the overall morbidity and mortality. The main aim of the study was to assess comorbidities of MG in a group of patients of East-European descent. We retrospectively compared 185 adult myasthenic patients with 895 sex- and age-matched controls, admitted from January 2013 to December 2021. Of these patients, 60% had late-onset MG (LOMG), with a clear predominance of women in both the LOMG and early-onset (EOMG) types; and 23.8% of the patients had a radiological description consistent with thymoma. All myasthenic patients had at least one comorbidity; 20 (10.8%) of the patients associated at least one autoimmune comorbidity. Obesity ( < 0.01), type 2 diabetes ( < 0.0001), cerebrovascular diseases ( < 0.0001), essential hypertension ( < 0.01), and cardiac arrythmias ( < 0.0001) were more frequent in patients than in the control group. The granulocyte-to-lymphocyte ratio was higher in the myasthenic patients compared to the controls ( < 0.01 for LOMG). We, thus, suggest a common chronic low-grade inflammatory background as a possible connection between MG subtypes and some of these apparently unconnected comorbidities. The East-European origin of the patients offered a different social and cultural angle of a disease studied mainly on populations of West-European and Asian descent.

摘要

随着重症肌无力(MG)患者预期寿命的延长,其合并症数量也在持续增加,这对总体发病率和死亡率可能产生重大影响。本研究的主要目的是评估一组东欧血统患者的MG合并症情况。我们回顾性比较了2013年1月至2021年12月收治的185例成年肌无力患者和895例性别及年龄匹配的对照者。在这些患者中,60%患有迟发性MG(LOMG),在LOMG和早发性(EOMG)类型中女性均明显占主导;23.8%的患者有与胸腺瘤一致的影像学描述。所有肌无力患者至少有一种合并症;20例(10.8%)患者至少有一种自身免疫性合并症。肥胖(<0.01)、2型糖尿病(<0.0001)、脑血管疾病(<0.0001)、原发性高血压(<0.01)和心律失常(<0.0001)在患者中比对照组更常见。与对照组相比,肌无力患者的粒细胞与淋巴细胞比值更高(LOMG为<0.01)。因此,我们认为常见的慢性低度炎症背景可能是MG亚型与其中一些明显无关的合并症之间的联系。患者的东欧血统为主要在西欧和亚洲血统人群中研究的疾病提供了不同的社会和文化视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11051044/481939aaa024/jcm-13-02273-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11051044/666914d90053/jcm-13-02273-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11051044/826e295867f0/jcm-13-02273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11051044/cc7f56ec6511/jcm-13-02273-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11051044/aa996f160f19/jcm-13-02273-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11051044/33dbb4260121/jcm-13-02273-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11051044/f7a2b6fac74b/jcm-13-02273-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11051044/46c0225f57af/jcm-13-02273-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11051044/481939aaa024/jcm-13-02273-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11051044/666914d90053/jcm-13-02273-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11051044/826e295867f0/jcm-13-02273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11051044/cc7f56ec6511/jcm-13-02273-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11051044/aa996f160f19/jcm-13-02273-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11051044/33dbb4260121/jcm-13-02273-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11051044/f7a2b6fac74b/jcm-13-02273-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11051044/46c0225f57af/jcm-13-02273-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd8/11051044/481939aaa024/jcm-13-02273-g008.jpg

相似文献

1
Autoimmune and Non-Autoimmune Comorbidities in Myasthenic Patients of East-European Descent: A Case-Control Study.东欧血统重症肌无力患者的自身免疫性和非自身免疫性合并症:一项病例对照研究。
J Clin Med. 2024 Apr 14;13(8):2273. doi: 10.3390/jcm13082273.
2
Clinical differences of early and late-onset myasthenia gravis in 985 patients.985例早发型和晚发型重症肌无力的临床差异
Neurol Res. 2019 Jan;41(1):45-51. doi: 10.1080/01616412.2018.1525121. Epub 2018 Oct 12.
3
Comorbidities in older patients with myasthenia gravis - Comparison between early- and late-onset disease.老年重症肌无力患者的合并症-早发与晚发疾病的比较。
Acta Neurol Scand. 2022 Mar;145(3):371-374. doi: 10.1111/ane.13549. Epub 2021 Nov 8.
4
Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis.自身免疫相关性和自身抗体筛查显示在全身性重症肌无力的患者亚组中存在集中识别。
Hum Immunol. 2013 Sep;74(9):1184-93. doi: 10.1016/j.humimm.2013.06.020. Epub 2013 Jun 18.
5
Outcome measures and treatment effectiveness in late onset myasthenia gravis.迟发性重症肌无力的疗效指标与治疗效果
Neurol Res Pract. 2020 Oct 30;2:45. doi: 10.1186/s42466-020-00091-z. eCollection 2020.
6
Characteristics of late-onset myasthenia gravis.迟发性重症肌无力的特征。
J Neurol. 2012 Oct;259(10):2167-71. doi: 10.1007/s00415-012-6478-6. Epub 2012 Apr 5.
7
Late-onset myasthenia gravis is predisposed to become generalized in the elderly.迟发性重症肌无力在老年人中易发展为全身性。
eNeurologicalSci. 2016 Feb 11;2:17-20. doi: 10.1016/j.ensci.2016.02.004. eCollection 2016 Mar.
8
Antititin antibody in early- and late-onset myasthenia gravis.早发型和晚发型重症肌无力中的抗肌联蛋白抗体
Acta Neurol Scand. 2014 Oct;130(4):229-33. doi: 10.1111/ane.12271. Epub 2014 Jun 20.
9
A study of comorbidities in myasthenia gravis.一项关于重症肌无力合并症的研究。
Acta Neurol Belg. 2020 Feb;120(1):59-64. doi: 10.1007/s13760-019-01102-w. Epub 2019 Apr 10.
10
The impact of thymectomy in subgroups of Myasthenia gravis patients: a single center longitudinal observation.胸腺切除术对重症肌无力患者亚组的影响:一项单中心纵向观察研究
Neurol Res Pract. 2023 Jun 15;5(1):24. doi: 10.1186/s42466-023-00252-w.

引用本文的文献

1
Diabetes mellitus in patients with myasthenia gravis: a systematic review and meta-analysis.重症肌无力患者的糖尿病:一项系统评价和荟萃分析。
Endocrine. 2025 Apr;88(1):24-35. doi: 10.1007/s12020-024-04143-1. Epub 2024 Dec 27.
2
HLA Class I and II Alleles in Anti-Acetylcholine Receptor Antibodies Positive and Double-Seronegative Myasthenia Gravis Patients of Romanian Descent.罗马尼亚裔抗乙酰胆碱受体抗体阳性和双血清阴性重症肌无力患者的HLA I类和II类等位基因
Neurol Int. 2024 Dec 10;16(6):1819-1836. doi: 10.3390/neurolint16060130.

本文引用的文献

1
[Lesions of the prevascular mediastinum].[血管前纵隔病变]
Radiologie (Heidelb). 2023 Mar;63(3):160-171. doi: 10.1007/s00117-023-01125-8. Epub 2023 Feb 16.
2
Inflammation and autoimmune myasthenia gravis.炎症与自身免疫性重症肌无力。
Front Immunol. 2023 Jan 30;14:1110499. doi: 10.3389/fimmu.2023.1110499. eCollection 2023.
3
Impact of Glucocorticoids on Cardiovascular System-The Yin Yang Effect.糖皮质激素对心血管系统的影响——阴阳效应
J Pers Med. 2022 Nov 3;12(11):1829. doi: 10.3390/jpm12111829.
4
Low-grade inflammation in type 2 diabetes: a cross-sectional study from a Danish diabetes outpatient clinic.2 型糖尿病中的低度炎症:丹麦糖尿病门诊的一项横断面研究。
BMJ Open. 2022 Dec 14;12(12):e062188. doi: 10.1136/bmjopen-2022-062188.
5
The systemic inflammation markers as possible indices for predicting respiratory failure and outcome in patients with myasthenia gravis.全身炎症标志物作为预测重症肌无力患者呼吸衰竭和预后的可能指标。
Ann Clin Transl Neurol. 2023 Jan;10(1):98-110. doi: 10.1002/acn3.51706. Epub 2022 Dec 1.
6
Correlation between neutrophil-to-lymphocyte ratio and severity of myasthenia gravis in adults: A retrospective study.成人重症肌无力患者中性粒细胞与淋巴细胞比值与病情严重程度的相关性:一项回顾性研究。
J Clin Neurosci. 2022 Dec;106:117-121. doi: 10.1016/j.jocn.2022.10.017. Epub 2022 Oct 22.
7
A retrospective longitudinal cohort study of the clinical burden in myasthenia gravis.一项重症肌无力临床负担的回顾性纵向队列研究。
BMC Neurol. 2022 May 9;22(1):172. doi: 10.1186/s12883-022-02692-4.
8
Advances and challenges in the treatment of myasthenia gravis.重症肌无力治疗的进展与挑战
Ther Adv Neurol Disord. 2021 Dec 21;14:17562864211065406. doi: 10.1177/17562864211065406. eCollection 2021.
9
Comorbid Autoimmune Diseases in Patients With Myasthenia Gravis: A Retrospective Cross-Sectional Study of a Chinese Cohort.重症肌无力患者的合并自身免疫性疾病:一项中国队列的回顾性横断面研究
Front Neurol. 2021 Nov 22;12:790941. doi: 10.3389/fneur.2021.790941. eCollection 2021.
10
Adverse Side Effects Associated with Corticosteroid Therapy: A Study in 39 Patients with Generalized Myasthenia Gravis.与皮质类固醇治疗相关的不良反应:39 例全身性重症肌无力患者的研究。
Med Sci Monit. 2021 Oct 28;27:e933296. doi: 10.12659/MSM.933296.